Denne reduktion i brugen af opioider var ledsaget af en signifikant reduktion i ubehag af opioidsymptomer rapporteret af patienterne.
The reduction in opioid use with Dynastat treatment on Days 2 and 3 was 7.2 mg and 2.8 mg (37% and 28% respectively). This reduction in opioid use was accompanied by significant reductions in patient-reported opioid symptom distress.